• Gregory S Weinstein, Roger Cohen, Alexander Lin, Bert W O'Malley, John Lukens, Samuel Swisher-McClure, Rabie M Shanti, Jason G Newman, Harman S Parhar, Kendall Tasche, Robert M Brody, Ara Chalian, Steven Cannady, James N Palmer, Nithin D Adappa, Michael A Kohanski, Joshua Bauml, Charu Aggarwal, Kathleen Montone, Virginia Livolsi, Zubair W Baloch, Jalal B Jalaly, Kumarasen Cooper, Karthik Rajasekaran, Laurie Loevner, and Christopher Rassekh.
• Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• Head Neck. 2020 Jul 1; 42 (7): 1507-1515.

IntroductionThe COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits.MethodsCreation of consensus document.ResultsThe process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system.ConclusionsThese guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.© 2020 Wiley Periodicals, Inc.

38 keywords...

hide…